RxDoctor Payments Data

Stephen Hawkins, MD

Family Medicine · Cabool, MONPI 1336188903

Payments from drug & device makers

$1,348in general payments, 2019–2025

Across 77 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$395
  • Lilly USA, LLC$147
  • Johnson & Johnson$145
  • Astellas Pharma US Inc$116
  • Novo Nordisk$106
  • Otsuka America Pharmaceutical, Inc.$84
  • plus $355 from 10 others

What the payments were for

  • Food & beverage$1,24893%
  • Education$1007%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,348 in reported general payments places this provider in the 65th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$38,597
Medicare patients
114
Services billed
393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban163$95,764
OzempicSemaglutide51$65,213
MounjaroTirzepatide39$55,989
Trelegy ElliptaFluticasone/Umeclidin/Vilanter79$54,126
JanuviaSitagliptin Phosphate66$50,535
EntrestoSacubitril/Valsartan44$46,491
FarxigaDapagliflozin Propanediol41$34,263
XareltoRivaroxaban28$26,562
JardianceEmpagliflozin26$25,859
TrulicityDulaglutide21$24,458
Breztri AerosphereBudesonide/Glycopyr/Formoterol38$23,849
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog64$16,954
Breo ElliptaFluticasone/Vilanterol31$11,646
PremarinEstrogens, Conjugated20$6,854
Gabapentin363$5,397

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$147$80,44760 claims
GSKTrelegy Ellipta, Breo Ellipta, Arexvy$78$70,035124 claims
Novo NordiskOzempic$106$65,21351 claims
AstraZenecaFarxiga, Breztri Aerosphere$395$58,11379 claims
NovartisEntresto$43$46,49144 claims
Johnson & JohnsonXarelto$145$26,56228 claims
Boehringer IngelheimJardiance$33$25,85926 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Cabool

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →